content

GSKs Latecomer Jemperli Beats Keytruda In Lung Cancer Trial

The standard therapy for newly diagnosed metastatic non-small cell lung cancer is Keytruda by Merck. That is the standard that PD-1 latecomer GSK's Jemperli...

Junk DNA Could Be The Key To Understanding Neuro Ailments

According to recent studies, there is a connection between non-coding DNA and some neurological diseases such as Alzheimer's and motor neurone disease. Researchers from the...

Genezen delivers next phase of cGMP lentiviral and retroviral vector production facility expansion

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, has completed another expansion phase...

Samsung Biologics introduces new development platforms S-DUAL and DEVELOPIC at BPI Boston 2022

Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary development technology platforms โ€“ S-DUALโ„ข and DEVELOPICKโ„ข โ€“ at...

To Accredit Medical Devices In The UK, MHRA Selects DEKRA

The three current UK-approved bodies have been joined by DEKRA Certification UK, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), enhancing the...

FDA Expanding Patient Participation In Drug Development

The FDA started a programme ten years ago to increase the role of patients in educating sponsors and regulators on the most detrimental impacts...

Maintain a Greater IDMP Strategy in a Changing Regulatory Landscape

After more than 10 years of preparation, the new Identification of Medicinal Products (IDMP) standard is set to go live in 2023. IDMP facilitates...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read